We are live on ! Find out more

691 hedge funds and large institutions have $13.4B invested in Xylem in 2019 Q2 according to their latest regulatory filings, with 75 funds opening new positions, 240 increasing their positions, 248 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 47

49% more call options, than puts

Call options by funds: $21.2M | Put options by funds: $14.2M

7% more capital invested

Capital invested by funds: $12.5B → $13.4B (+$909M)

3% more funds holding

Funds holding: 670691 (+21)

3% less repeat investments, than reductions

Existing positions increased: 240 | Existing positions reduced: 248

1.1% less ownership

Funds ownership: 88.11%87.01% (-1.1%)

8% less funds holding in top 10

Funds holding in top 10: 1312 (-1)

Holders
691
Holders Change
+21
Holders Change %
+3.13%
% of All Funds
14.94%
Holding in Top 10
12
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.69%
% of All Funds
0.26%
New
75
Increased
240
Reduced
248
Closed
47
Calls
$21.2M
Puts
$14.2M
Net Calls
+$6.96M
Net Calls Change
-$3.39M

XYL Hedge Fund Activity: Q2 2019 in Review

691 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Xylem (XYL) for Q2 2019, worth a combined $13.4B — up 7.3% from $12.5B a quarter earlier.

Buyers outnumbered sellers: 75 funds opened new XYL positions and 47 closed out — a net gain of 28 holders — while 240 added to existing stakes and 248 trimmed.

The largest buyer was Nuveen, adding an estimated $44.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $91.7M.

  • 691 institutional investors held Xylem (XYL) as of Q2 2019, up from 670 in Q1 2019.
  • Funds reported $13.4B of Xylem stock for Q2 2019, up 7.3% quarter-over-quarter.
  • 75 funds opened new Xylem positions in Q2 2019 and 47 closed out, a net change of +28 holders.
  • The largest Xylem buyer in Q2 2019 was Nuveen, an estimated $44.4M added.
  • The largest Xylem seller in Q2 2019 was T. Rowe Price Associates, an estimated $91.7M sold.

Based on aggregated 13F filings for Q2 2019.